Hematologic Oncology Update, Issue 3, 2016 (Video Program) - Video 21


Activity of ruxolitinib in myeloproliferative neoplasms and therapeutic options for patients who experience a response followed by disease progression
2:23 minutes.

Non-Hodgkin lymphoma (NHL), Hodgkin lymphoma and chronic lymphocytic leukemia (CLL)

Acute and chronic leukemias and myeloproliferative neoplasms

Multiple myeloma (MM)